MEIP

MEI Pharma Inc.

Price

return (12m)

0.00%

p/e

-0.96

p/bv

1.05

DIVIDEND YIELD

0.00%

MEIP price

MEI Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MEIP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals MEIP

Valuation

P/E

-0.96

Sector -4.03

Industry -4.03

P/BV

1.05

Sector 2.05

Industry 2.05

P/Revenue (PSR)

Sector -4.26

Industry -4.26

EV/EBITDA

-0.01

Sector -238.32

Industry -238.32

EV/EBIT

-0.01

Sector -670.55

Industry -670.55

P/EBITDA

-0.92

Sector -4.23

Industry -4.23

P/EBIT

-0.89

Sector -4.29

Industry -4.29

P/Total Assets

0.99

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

1.05

Sector -11.51

Industry -11.51

P/Cap.Giro

1.05

Sector -11.45

Industry -11.45

EPS

-3.04

Sector -2.20

Industry -2.20

BVPS

2.79

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

0.00%

Sector 36.28%

Industry 36.28%

EBITDA Margin

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

0.00%

Sector -38.78%

Industry -38.78%

Net Profit Margins

0.00%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-108.85%

Sector -65.93%

Industry -65.93%

ROA

-102.36%

Sector -66.10%

Industry -66.10%

ROIC

-996.05%

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

16.78

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

7.39

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

7.39

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-1.05

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

0.00

Sector -0.10

Industry -0.10

Equity/Assets

0.94

Sector 0.42

Industry 0.42

Liabilities/Assets

0.06

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-13.35%

Sector -

Industry -

Fundamentals MEIP

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
MEIP	-0.96	1.05	-108.85%	0.00%	$20.51 M	0.00%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MEIP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/15/2023	12/06/2023	1.75000000

ABOUT MEI Pharma

MEI Pharma Inc.

Average Investor10 user rating

4.0 (2 people)

United States

26 years

Founded: 2000

2003

Time since IPO - 23 years

76

Employees

MEI Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $20.51 million, with shareholders equity totaling $19.54 million.

The company employs approximately 76 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, MEI Pharma Inc. reported $- in revenue, generating net income of $-21.27 million.

Key financial metrics include a P/E ratio of -0.96, a price-to-book (P/B) ratio of 1.05, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MEIP.

Market cap

$20.51 million

Net worth

$19.54 million

$19,540,000.00

Assets

$20.78 million

$20,780,000.00

Total Shares Outstanding

7.00 million

7,000,000

Average Daily Trading Volume

$1.77 million

$1,770,937.30

Sector

Health Care

Industry

Biotechnology

MEIP

MEIP revenue and profits

Financial Results MEIP

DRAG THE FRAME TO SEE MORE DATA

MEIP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$850.06 20,98% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$229.35 48,25% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$130.76 60,71% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$169.64 16,66% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$256.91 41,83% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$850.06 20,98% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$229.35 48,25% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$265.95 64,85% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$130.76 60,71% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$169.64 16,66% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$256.91 41,83% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$49.67 --3,46% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of MEI Pharma (MEIP) today?

A cotação de MEI Pharma (MEIP) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de MEI Pharma (MEIP) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de MEI Pharma (MEIP) e dados de ações do Ibovespa e mercados internacionais.

Quando MEI Pharma (MEIP) paga dividendos?

MEI Pharma (MEIP) não distribuiu dividendos no último ano.

Is MEI Pharma (MEIP) a good investment?

Atualmente, MEI Pharma (MEIP) está cotada a US$ 0.00, com um P/L de -0.96, representando um desvio de -30% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy MEI Pharma (MEIP) stock?

Investir em ações de MEI Pharma (MEIP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of MEI Pharma (MEIP) yield today?

A rentabilidade de MEI Pharma (MEIP) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de MEI Pharma (MEIP) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MEIP

MEI Pharma Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MEIP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

type

Ex - Dividend Date

payment date

value

ABOUT MEI Pharma

MEI Pharma Inc.

United States

26 years

2003

76

PROFIT X PRICE MEIP

Financial Results MEIP

MEIP cash flow

Asset, Revenue and Profit Growth - MEIP

MEIP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions